|
|
|
|
Reata Pharmaceuticals Inc (NASDAQ: RETA) |
|
|
|
| |
Reata Pharmaceuticals Inc Accounts Receivables Turnover Ratio from the second quarter 2023 to the second quarter 2022
Quarterly Results, Trends, Rankings, Statistics
Reata Pharmaceuticals Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the second quarter 2023 to a ratio of 4.14, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the second quarter 2023. Reata Pharmaceuticals Inc 's Accounts Receivable average collection period in the Jun 30 2023 quarter, | |